Aelis Farma SA (EPA:AELIS)
France · Delayed Price · Currency is EUR 1.355
+0.215 (18.86%)
Sep 15, 2025, 4:29 PM CET
Aelis Farma Revenue
In the year 2024, Aelis Farma had annual revenue of 5.56M EUR, down -54.99%. Aelis Farma had revenue of 1.44M in the half year ending December 31, 2024, a decrease of -65.04%.
Revenue
5.56M
Revenue Growth
-54.99%
P/S Ratio
2.79
Revenue / Employee
198.64K
Employees
28
Market Cap
15.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.56M | -6.80M | -54.99% |
| Dec 31, 2023 | 12.36M | 3.99M | 47.75% |
| Dec 31, 2022 | 8.36M | -2.40M | -22.28% |
| Dec 31, 2021 | 10.76M | 9.63M | 846.53% |
| Dec 31, 2020 | 1.14M | 1.13M | 12,746.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.74B |
| Sartorius Stedim Biotech | 2.90B |
| bioMérieux | 4.12B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 6.02M |
| Virbac | 1.43B |